Pentagon Awards Raytheon $20.7B AMRAAM Contract to Nearly Double Production
The Pentagon awarded Raytheon a five-year multiyear contract on September 25, announced September 28-29, with a $20.7 billion ceiling and two optional years—six times the previous record $3.5 billion award from July 2025. The contract is jointly funded by the Air Force, Navy, and allied customers. Raytheon committed in February 2026 to a production rate of at least 1,900 AMRAAM missiles annually under framework agreements, but lacked formal contract authority to execute capital investment at that scale. This award provides that authority, though Reuters reports the deal is provisional: Congress has not yet appropriated funds against the ceiling, and industry executives have withheld supply-chain and factory expansion spending pending legislative action. The Pentagon's statement thanked Congress for multiyear procurement authority and signaled hope for additional funding, indicating the full $20.7 billion remains contingent on FY27 appropriations.
The contract's magnitude reflects a shift from episodic procurement to structural demand commitment—the Pentagon is betting that the drawdown from the Iran war will persist long enough to justify locking in production capacity rather than buying missiles on annual cycles. This inversion of procurement risk from the Pentagon to Raytheon's balance sheet creates a second-order constraint: if RTX accelerates hiring and tooling investment in Q4 2026 based on the contract ceiling but Congress appropriates only a fraction of the $20.7 billion, the company faces write-downs and workforce reductions that will ripple through its supply base and equity valuation. Lockheed Martin's concurrent AIM-260 framework agreement (announced earlier in September per Air & Space Forces Magazine) signals the Pentagon is hedging against AMRAAM supply constraints by maturing a successor production line in parallel. If Raytheon cannot sustain the 1,900-unit annual rate despite the contract authority, the Air Force has a contractual path to shift volume to Lockheed—a scenario that would expose RTX's production claims as optimistic and force a renegotiation of the multiyear commitment.
Raytheon must now decide whether to commit capital on the strength of a provisional contract, or wait for congressional appropriation and risk losing market share if Lockheed's AIM-260 matures faster.
Raytheon now has explicit Pentagon authority to commit to 1,900 AMRAAM missiles annually, but the $20.7 billion contract ceiling is provisional pending congressional appropriation—a critical distinction that determines whether the company will invest in supply-chain and factory expansion or hold capital pending legislative action.
The six-fold jump from the 2025 benchmark reflects the Pentagon's shift from episodic to multiyear procurement, signaling that the Iran war's munitions drawdown is structural, not cyclical. Watch whether RTX accelerates hiring and tooling investment in Q4 2026, and monitor congressional FY27 appropriations against the $20.7 billion ceiling; if lawmakers fund only a fraction of the award, RTX will face pressure to revise the February framework commitments downward. Lockheed Martin's concurrent AIM-260 framework deal creates a hedge against AMRAAM supply constraints, meaning RTX's production rate is now benchmarked against a competitor's timeline rather than against abstract demand.
Has Congress appropriated funds against the $20.7B ceiling, or is this a provisional award contingent on FY27 supplemental funding?
Fault Lines
Strategic intelligence, synthesized daily — with a public track record. Every call graded against what actually happened.